Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    • News

  • Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards
    Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards
    • News

  • Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    • News

  • Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program
    Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program
    • News

  • Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    • News

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

Healthia expands allied health footprint with new VIC and NSW acquisitions

  • In News
  • April 29, 2022
  • Alfred Chan
Healthia expands allied health footprint with new VIC and NSW acquisitions

Emerging healthcare juggernaut Healthia (ASX: HLA) has continued to expand its national footprint as Australia’s fastest growing allied health portfolio, this time acquiring six new clinics across Victoria and New South Wales.

The new additions include four hand therapy clinics and a physiotherapy clinic in Melbourne as well as one optometry clinic in Singleton, New South Wales. They take Healthia’s portfolio to 306 allied health businesses across Australia, New Zealand and the United States.

That number has grown from just 102 clinics when Healthia listed on the ASX in 2018 but the Company has continued to execute on their strategy, deploying at least $20m in capital towards acquisitions that Healthia can substantially improve with their vertical integration services.

“With Healthia having deployed $19.1 million during FY22 (excluding the Back In Motion acquisition) and a strong acquisition target pipeline, I am confident we will meet our target of deploying $20m capital during FY22 and again in FY23,” said Healthia CEO, Wesley Coote.

Since June 2021, Healthia has deployed $110.8 million towards acquisitions which included their major acquisition of Back In Motion’s 63 physiotherapy clinics which also facilitated Healthia’s expansion into New Zealand.

Operating three main divisions covering podiatry, physiotherapy and optometry, Healthia is regularly approached by independent clinic operators keen to join the Healthia network to gain access to its support, education programs and marketing services.

Total upfront consideration for the acquisitions is $1.83m comprising $1.4m cash and $0.43m in Clinic Class Shares whereby the vendors will retain equity in the clinics that entitles them to a portion of profits generated. An additional $0.21m may be payable subject to performance targets.

Combined, the acquired clinics will contribute $2.65 million in underlying revenue and $0.46 million underlying EBITDA on an annualised basis which represents an attractive purchase multiple of 3.97x EBITDA.

While some of Healthia’s operations have been impacted over the past 6 months by the lingering effects of COVID-19, the resumption of normal operations has the Company in a strong position going forward to recoup appointments cancelled during lockdowns.

Between their 292 clinics prior to this new round of acquisitions, 6,869 clinic trading days were impacted due to COVID related Government imposed restrictions and lockdowns in the first 6 months of this financial year. This meant there were restrictions on marketing podiatry and optometry services in December which is typically one of the biggest months for sales as Aussies seek to claim their private health insurance benefits which lapse at the end of each calendar year.

Unlikely to see those benefits lapse in consecutive years, Healthia is well placed to service those missed appointments in 2022 where they have recently entered into an agreement with BUPA to be an “BUPA Optical Partner” to service their membership base.

Further fueling their rapid expansion, Healthia has undertaken their largest graduate intake ever with 154 new clinicians commencing their career with Healthia, an intake more than double the 64 hired last year.

Assuming there are no further COVID impacts across their national network, Healthia expects to commence FY23 with more than $40 million in annualised EBITDA in their portfolio which is almost double the $21.4m reported in FY21.

Further strengthening their portfolio, Healthia was recently admitted to the All-Ordinaries index which represents the top 500 companies listed on the ASX.

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications
  •  
  •  
  •  
  •  
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.